COMMUNIQUÉS West-GlobeNewswire
-
Intellia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04/09/2026 -
Avalo Therapeutics Announces Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)
04/09/2026 -
Rapid Micro Biosystems to Participate in Upcoming Investor Conferences
04/09/2026 -
Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04/09/2026 -
Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
04/09/2026 -
Kiniksa Pharmaceuticals to Present at Wells Fargo 21st Annual Healthcare Conference
04/09/2026 -
InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04/09/2026 -
Apnimed, Inc. Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
04/09/2026 -
Spyre Therapeutics Announces Grants of Inducement Awards
04/09/2026 -
Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
04/09/2026 -
Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04/09/2026 -
TerrAscend to Participate in the ATB Cormark Capital Markets 2026 Life Sciences Fall Institutional Investor Conference
04/09/2026 -
Orion Corporation: Acquisition of own shares during week 36, 2026
04/09/2026 -
Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such
04/09/2026 -
Declaration of shares and voting rights - Status as of August 31, 2026
04/09/2026 -
Déclaration d’actions et de droits de vote - Statut au 31 août 2026
04/09/2026 -
Polyrizon Ltd. Announces Closing of $4.0 Million Registered Direct Offering and Private Placement
04/09/2026 -
S&P Global Ratings Upgrades Teva to BBB-, Marking Third Credit Rating Upgrade in Recent Months and Reflecting Strong Execution and Financial Discipline
04/09/2026 -
Wandercraft Secures 12 Calvin-40 Customers as It Accelerates Commercial Dominance in Industrial Humanoids
04/09/2026
Pages